154 related articles for article (PubMed ID: 31683663)
1. Population Pharmacokinetics Modelling and Simulation of Mitotane in Patients with Adrenocortical Carcinoma: An Individualized Dose Regimen to Target All Patients at Three Months?
Cazaubon Y; Talineau Y; Feliu C; Konecki C; Russello J; Mathieu O; Djerada Z
Pharmaceutics; 2019 Oct; 11(11):. PubMed ID: 31683663
[TBL] [Abstract][Full Text] [Related]
2. Population Pharmacokinetic and Pharmacogenetic Analysis of Mitotane in Patients with Adrenocortical Carcinoma: Towards Individualized Dosing.
Yin A; Ettaieb MHT; Swen JJ; van Deun L; Kerkhofs TMA; van der Straaten RJHM; Corssmit EPM; Gelderblom H; Kerstens MN; Feelders RA; Eekhoff M; Timmers HJLM; D'Avolio A; Cusato J; Guchelaar HJ; Haak HR; Moes DJAR
Clin Pharmacokinet; 2021 Jan; 60(1):89-102. PubMed ID: 32607875
[TBL] [Abstract][Full Text] [Related]
3. Enzyme autoinduction by mitotane supported by population pharmacokinetic modelling in a large cohort of adrenocortical carcinoma patients.
Arshad U; Taubert M; Kurlbaum M; Frechen S; Herterich S; Megerle F; Hamacher S; Fassnacht M; Fuhr U; Kroiss M
Eur J Endocrinol; 2018 Oct; 179(5):287-297. PubMed ID: 30087117
[TBL] [Abstract][Full Text] [Related]
4. Development of a pharmacokinetic model of mitotane: toward personalized dosing in adrenocortical carcinoma.
Kerkhofs TM; Derijks LJ; Ettaieb H; den Hartigh J; Neef K; Gelderblom H; Guchelaar HJ; Haak HR
Ther Drug Monit; 2015 Feb; 37(1):58-65. PubMed ID: 24887633
[TBL] [Abstract][Full Text] [Related]
5. Population Pharmacokinetics of Isavuconazole in Critical Care Patients with COVID-19-Associated Pulmonary Aspergillosis and Monte Carlo Simulations of High Off-Label Doses.
Perez L; Corne P; Pasquier G; Konecki C; Sadek M; Le Bihan C; Klouche K; Mathieu O; Reynes J; Cazaubon Y
J Fungi (Basel); 2023 Feb; 9(2):. PubMed ID: 36836325
[TBL] [Abstract][Full Text] [Related]
6. Comparison of two mitotane starting dose regimens in patients with advanced adrenocortical carcinoma.
Kerkhofs TM; Baudin E; Terzolo M; Allolio B; Chadarevian R; Mueller HH; Skogseid B; Leboulleux S; Mantero F; Haak HR; Fassnacht M
J Clin Endocrinol Metab; 2013 Dec; 98(12):4759-67. PubMed ID: 24057287
[TBL] [Abstract][Full Text] [Related]
7. Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment.
Puglisi S; Calabrese A; Basile V; Ceccato F; Scaroni C; Simeoli C; Torlontano M; Cannavò S; Arnaldi G; Stigliano A; Malandrino P; Saba L; Altieri B; Della Casa S; Perotti P; Berchialla P; De Filpo G; Canu L; Loli P; Reimondo G; Terzolo M
J Clin Med; 2019 Nov; 8(11):. PubMed ID: 31684071
[TBL] [Abstract][Full Text] [Related]
8. Selection of dosing regimen with WST11 by Monte Carlo simulations, using PK data collected after single IV administration in healthy subjects and population PK modeling.
Fabre MA; Fuseau E; Ficheux H
J Pharm Sci; 2007 Dec; 96(12):3444-56. PubMed ID: 17854075
[TBL] [Abstract][Full Text] [Related]
9. Population pharmacokinetics of teicoplanin administered by subcutaneous or intravenous route and simulation of optimal loading dose regimen.
Cazaubon Y; Venisse N; Mimoz O; Maire P; Ducher M; Bourguignon L; Goutelle S
J Antimicrob Chemother; 2017 Oct; 72(10):2804-2812. PubMed ID: 29091222
[TBL] [Abstract][Full Text] [Related]
10. Dosing Optimization of Posaconazole in Lung-Transplant Recipients Based on Population Pharmacokinetic Model.
Dvořáčková E; Šíma M; Zajacová A; Vyskočilová K; Kotowski T; Dunovská K; Klapková E; Havlín J; Lischke R; Slanař O
Antibiotics (Basel); 2023 Sep; 12(9):. PubMed ID: 37760696
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Aztreonam Dosing Regimens in Patients With Normal and Impaired Renal Function: A Population Pharmacokinetic Modeling and Monte Carlo Simulation Analysis.
Xu H; Zhou W; Zhou D; Li J; Al-Huniti N
J Clin Pharmacol; 2017 Mar; 57(3):336-344. PubMed ID: 27530649
[TBL] [Abstract][Full Text] [Related]
12. Real Life Population Pharmacokinetics Modelling of Eight Factors VIII in Patients with Severe Haemophilia A: Is It Always Relevant to Switch to an Extended Half-Life?
Allard Q; Djerada Z; Pouplard C; Repessé Y; Desprez D; Galinat H; Frotscher B; Berger C; Harroche A; Ryman A; Flaujac C; Chamouni P; Guillet B; Volot F; Szymezak J; Nguyen P; Cazaubon Y
Pharmaceutics; 2020 Apr; 12(4):. PubMed ID: 32326156
[TBL] [Abstract][Full Text] [Related]
13. Dosing of IV posaconazole to treat critically ill patients with invasive pulmonary aspergillosis: a population pharmacokinetics modelling and simulation study.
Elkayal O; Mertens B; Wauters J; Debaveye Y; Rijnders B; Verweij PE; Brüggemann RJ; Spriet I; Dreesen E
J Antimicrob Chemother; 2024 Jun; ():. PubMed ID: 38828958
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetics of cefepime in febrile neutropenia: implications for dose-dependent susceptibility and contemporary dosing regimens.
Rhodes NJ; Grove ME; Kiel PJ; O'Donnell JN; Whited LK; Rose DT; Jones DR; Scheetz MH
Int J Antimicrob Agents; 2017 Sep; 50(3):482-486. PubMed ID: 28668694
[TBL] [Abstract][Full Text] [Related]
15. High-dose mitotane strategy in adrenocortical carcinoma: prospective analysis of plasma mitotane measurement during the first 3 months of follow-up.
Mauclère-Denost S; Leboulleux S; Borget I; Paci A; Young J; Al Ghuzlan A; Deandreis D; Drouard L; Tabarin A; Chanson P; Schlumberger M; Baudin E
Eur J Endocrinol; 2012 Feb; 166(2):261-8. PubMed ID: 22048971
[TBL] [Abstract][Full Text] [Related]
16. Population Pharmacokinetic Model-Based Evaluation of Standard Dosing Regimens for Cefuroxime Used in Coronary Artery Bypass Graft Surgery with Cardiopulmonary Bypass.
Alqahtani SA; Alsultan AS; Alqattan HM; Eldemerdash A; Albacker TB
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29358296
[TBL] [Abstract][Full Text] [Related]
17. Population Pharmacokinetic Model to Optimize Cefotaxime Dosing Regimen in Critically Ill Children.
Béranger A; Oualha M; Urien S; Genuini M; Renolleau S; Aboura R; Hirt D; Heilbronner C; Toubiana J; Tréluyer JM; Benaboud S
Clin Pharmacokinet; 2018 Jul; 57(7):867-875. PubMed ID: 28980166
[TBL] [Abstract][Full Text] [Related]
18. Population pharmacokinetics of intravenous sufentanil in critically ill patients supported with extracorporeal membrane oxygenation therapy.
Hahn J; Yang S; Min KL; Kim D; Jin BH; Park C; Park MS; Wi J; Chang MJ
Crit Care; 2019 Jul; 23(1):248. PubMed ID: 31288863
[TBL] [Abstract][Full Text] [Related]
19. Piperacillin Population Pharmacokinetics and Dosing Regimen Optimization in Critically Ill Children with Normal and Augmented Renal Clearance.
Béranger A; Benaboud S; Urien S; Moulin F; Bille E; Lesage F; Zheng Y; Genuini M; Gana I; Renolleau S; Hirt D; Tréluyer JM; Oualha M
Clin Pharmacokinet; 2019 Feb; 58(2):223-233. PubMed ID: 29862466
[TBL] [Abstract][Full Text] [Related]
20. Characterization of hyperlipidemia secondary to mitotane in adrenocortical carcinoma.
Gagnon N; Bernard S; Paquette M; Alguire C; Lacroix A; Hétu PO; Olney HJ; Bourdeau I
Endocr Oncol; 2022 Jan; 2(1):1-8. PubMed ID: 37435450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
